|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/24 | |||
| C07K 16/28 | |||
| C12N 15/113 | |||
| A61P 25/28 |
| (11) | Number of the document | 2547363 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11710004.0 |
| Date of filing the European patent application | 2011-02-17 | |
| (97) | Date of publication of the European application | 2013-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2011/000220 |
| Date | 2011-02-17 |
| (87) | Number | WO 2011/101634 |
| Date | 2011-08-25 |
| (30) | Number | Date | Country code |
| 305500 P | 2010-02-17 | US |
| (72) |
MAZE, Mervyn, US
FELDMAN, Marc, GB
TERRANDO, Niccolo, US
CIBELLI, Mario, GB
MA, Daqing, GB
FERTLEMAN, Michael, GB
NANCHAHAL, Jagdeep, GB
|
| (73) |
THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH,
Boundary House 91 Charterhouse Street, London EC1M 6HR,
GB
|
| (54) | METHODS OF PREVENTION OR TREATMENT OF TRIGGERED INFLAMMATORY REACTIONS USING TUMOR NECROSIS FACTOR ALPHA ANTAGONIST |
| METHODS OF PREVENTION OR TREATMENT OF TRIGGERED INFLAMMATORY REACTIONS USING TUMOR NECROSIS FACTOR ALPHA ANTAGONIST |